Peter A Ward Selected Research

Punctures

1/2019	GM-CSF Administration Improves Defects in Innate Immunity and Sepsis Survival in Obese Diabetic Mice.
10/2018	Role of complement C5a and histones in septic cardiomyopathy.
1/2018	Harmful Roles of TLR3 and TLR9 in Cardiac Dysfunction Developing during Polymicrobial Sepsis.
12/2016	Complement-induced activation of the cardiac NLRP3 inflammasome in sepsis.
5/2015	Role of extracellular histones in the cardiomyopathy of sepsis.
3/2015	Organ distribution of histones after intravenous infusion of FITC histones or after sepsis.
2/2015	Cutting edge: critical role for C5aRs in the development of septic lymphopenia in mice.
12/2014	Interruption of macrophage-derived IL-27(p28) production by IL-10 during sepsis requires STAT3 but not SOCS3.
1/2014	Persistent neutrophil dysfunction and suppression of acute lung injury in mice following cecal ligation and puncture sepsis.
7/2013	The interaction between C5a and both C5aR and C5L2 receptors is required for production of G-CSF during acute inflammation.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter A Ward Research Topics

Disease

82	Sepsis (Septicemia) 11/2020 - 05/2002
30	Inflammation (Inflammations) 01/2021 - 07/2002
30	Acute Lung Injury 01/2017 - 07/2002
14	Lung Injury 05/2016 - 07/2002
8	Cardiomyopathies (Cardiomyopathy) 01/2020 - 01/2006
8	Infections 01/2019 - 05/2002
8	Pneumonia (Pneumonitis) 06/2015 - 09/2002
6	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 05/2016 - 12/2004
6	Shock 12/2014 - 05/2002
6	Hemorrhage 11/2009 - 07/2002
5	Hemorrhagic Shock 09/2008 - 05/2002
4	Ischemia 01/2021 - 09/2002
4	Autoimmune Diseases (Autoimmune Disease) 01/2016 - 06/2006
4	Wounds and Injuries (Trauma) 08/2015 - 05/2007
4	Endotoxemia 04/2013 - 12/2011
3	Septic Shock (Toxic Shock Syndrome) 01/2017 - 01/2012
3	Reperfusion Injury 07/2014 - 02/2003
3	Edema (Dropsy) 12/2013 - 07/2002
3	Bacteremia 10/2008 - 07/2005
2	Blister (Bulla) 01/2018 - 01/2014
2	Vasculitis (Vasculitides) 01/2016 - 12/2004
2	Malaria 09/2015 - 05/2008
2	Brain Ischemia (Cerebral Ischemia) 07/2014 - 09/2008
2	Fibrosis (Cirrhosis) 05/2008 - 06/2005
2	Bacterial Infections (Bacterial Infection) 09/2005 - 09/2004
2	Pulmonary Edema 03/2005 - 11/2004
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2019
1	Obesity 01/2018
1	Weight Loss (Weight Reduction) 01/2018

Drug/Important Bio-Agent (IBA)

46	Complement System Proteins (Complement)IBA 11/2020 - 07/2002
29	CytokinesIBA 01/2020 - 08/2002
22	Anaphylatoxin C5a ReceptorIBA 01/2020 - 06/2002
16	ChemokinesIBA 01/2020 - 08/2002
15	Histones (Histone)IBA 11/2020 - 12/2013
14	AnaphylatoxinsIBA 11/2020 - 05/2002
12	Antigen-Antibody Complex (Immune Complex)IBA 01/2016 - 07/2002
11	Immunoglobulin G (IgG)IBA 01/2016 - 07/2002
10	Proteins (Proteins, Gene)FDA Link 01/2019 - 05/2002
7	Messenger RNA (mRNA)IBA 01/2016 - 07/2002
7	LipopolysaccharidesIBA 01/2014 - 05/2002
6	Pharmaceutical PreparationsIBA 01/2020 - 05/2002
6	CatecholaminesIBA 01/2014 - 10/2007
6	Interleukin-17 (Interleukin 17)IBA 04/2013 - 07/2008
6	salicylhydroxamic acid (SHAM)IBA 04/2013 - 05/2002
6	Oxidants (Oxidizing Agents)IBA 12/2012 - 01/2006
6	Interleukin-6 (Interleukin 6)IBA 07/2011 - 01/2003
5	EndotoxinsIBA 12/2012 - 12/2005
5	Nitric Oxide (Nitrogen Monoxide)FDA Link 07/2008 - 09/2002
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 11/2004
4	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 11/2020 - 12/2010
4	Complement C5a (Complement 5a)IBA 10/2018 - 01/2009
4	InflammasomesIBA 10/2018 - 06/2014
4	Neutralizing AntibodiesIBA 01/2017 - 07/2011
4	AntioxidantsIBA 07/2011 - 03/2006
4	SelectinsIBA 09/2008 - 05/2002
3	SolutionsIBA 01/2021 - 07/2008
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019 - 12/2003
3	Adenosine Triphosphatases (ATPase)IBA 01/2019 - 01/2016
3	Interleukin-10 (Interleukin 10)IBA 12/2014 - 12/2002
3	Interleukin-27 (Interleukin 27)IBA 12/2014 - 12/2013
3	Liposomes (Liposome)IBA 12/2014 - 03/2006
3	Interleukin-23 (Interleukin 23)IBA 05/2013 - 04/2012
3	Oxygen (Dioxygen)IBA 07/2011 - 07/2002
3	AntibodiesIBA 07/2008 - 05/2002
3	Nitroprusside (Sodium Nitroprusside)FDA LinkGeneric 07/2008 - 09/2003
3	2-chloroethyl ethyl sulfideIBA 05/2008 - 07/2002
2	AlbuminsIBA 01/2017 - 03/2005
2	Complement Receptors (Complement Receptor)IBA 01/2016 - 12/2004
2	CCR ReceptorsIBA 09/2015 - 12/2004
2	GlucocorticoidsIBA 08/2015 - 04/2013
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 07/2013 - 04/2007
2	IntegrinsIBA 01/2012 - 07/2002
2	Saline SolutionIBA 09/2010 - 11/2004
2	Ringer's LactateIBA 09/2010 - 07/2008
2	EnzymesIBA 08/2010 - 10/2007
2	bimosiamose disodiumIBA 09/2008 - 05/2002
2	Nitric Oxide DonorsIBA 07/2008 - 11/2004
2	Glutathione (Reduced Glutathione)IBA 05/2008 - 03/2006
2	Transcription Factors (Transcription Factor)IBA 11/2007 - 01/2006
2	NF-kappa B (NF-kB)IBA 09/2006 - 08/2003
2	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 09/2006 - 07/2002
2	CXC ChemokinesIBA 07/2006 - 10/2003
2	Serum AlbuminIBA 03/2006 - 07/2002
2	Mustard Gas (Sulfur Mustard)IBA 03/2006 - 07/2002
2	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 03/2005 - 04/2004
2	Ribonucleases (Ribonuclease)IBA 03/2005 - 11/2004
2	Peroxidase (Myeloperoxidase)IBA 03/2005 - 10/2003
2	Arginine (L-Arginine)FDA Link 11/2004 - 09/2003
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 09/2003 - 09/2002
1	InterferonsIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	eculizumab FDA Link 11/2020
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2019

Therapy/Procedure

42	Punctures 01/2019 - 05/2002
42	Ligation 01/2019 - 05/2002
10	Therapeutics 01/2017 - 08/2003
4	Critical Care (Surgical Intensive Care) 01/2017 - 04/2012
4	Resuscitation 07/2008 - 05/2002
2	Drug Therapy (Chemotherapy) 05/2016 - 04/2012
2	Surgical Amputation (Amputations) 07/2008 - 05/2002